NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT06385925 2025-12-15A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D MutationTyligand Pharmaceuticals (Suzhou) LimitedPhase 1/2 Recruiting440 enrolled
NCT01803282 2020-06-02Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid TumorsGilead SciencesPhase 1 Completed236 enrolled 21 charts
NCT00019513 2012-03-23Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Completed108 enrolled